abrdn Life Sciences Investors (HQL) to Issue Quarterly Dividend of $0.50 on January 12th

abrdn Life Sciences Investors (NYSE:HQL) declared a quarterly dividend on Tuesday, November 11th. Shareholders of record on Friday, November 21st will be given a dividend of 0.50 per share on Monday, January 12th. This represents a c) dividend on an annualized basis and a yield of 11.6%. The ex-dividend date of this dividend is Friday, November 21st. This is a 19.0% increase from abrdn Life Sciences Investors’s previous quarterly dividend of $0.42.

abrdn Life Sciences Investors Stock Performance

HQL stock opened at $17.24 on Wednesday. The business has a 50 day simple moving average of $15.89 and a 200-day simple moving average of $14.05. abrdn Life Sciences Investors has a 1 year low of $10.55 and a 1 year high of $17.80.

Insider Transactions at abrdn Life Sciences Investors

In other abrdn Life Sciences Investors news, major shareholder Saba Capital Management, L.P. sold 41,623 shares of the firm’s stock in a transaction on Monday, September 22nd. The stock was sold at an average price of $14.14, for a total value of $588,549.22. Following the completion of the sale, the insider directly owned 2,837,633 shares of the company’s stock, valued at $40,124,130.62. This trade represents a 1.45% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. In the last three months, insiders sold 179,906 shares of company stock valued at $2,530,720. 10.06% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently modified their holdings of the company. Kingsview Wealth Management LLC increased its position in abrdn Life Sciences Investors by 3.1% during the first quarter. Kingsview Wealth Management LLC now owns 35,743 shares of the company’s stock worth $454,000 after purchasing an additional 1,060 shares during the last quarter. Private Advisor Group LLC grew its stake in shares of abrdn Life Sciences Investors by 5.0% in the 1st quarter. Private Advisor Group LLC now owns 23,075 shares of the company’s stock valued at $293,000 after buying an additional 1,097 shares during the period. Wedbush Securities Inc. purchased a new stake in shares of abrdn Life Sciences Investors in the 1st quarter valued at approximately $149,000. LPL Financial LLC increased its holdings in shares of abrdn Life Sciences Investors by 14.4% during the 1st quarter. LPL Financial LLC now owns 328,402 shares of the company’s stock worth $4,167,000 after buying an additional 41,307 shares during the last quarter. Finally, Shaker Financial Services LLC purchased a new stake in shares of abrdn Life Sciences Investors during the 1st quarter valued at approximately $297,000. Institutional investors and hedge funds own 32.21% of the company’s stock.

About abrdn Life Sciences Investors

Abrdn Life Sciences Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical equipment, hospitals, healthcare information technology and services, devices and supplies industries, and in agriculture and environmental management industries.